T 0435/20 (Anti-IL-23 antibodies binding at conformational epitope/MERCK SHARP & DOHME) of 14.07.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T043520.20220714
- Date of decision
- 14 July 2022
- Case number
- T 0435/20
- Petition for review of
- -
- Application number
- 06802592.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Engineered anti-IL-23 antibodies
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- (1) Eli Lilly and Company (opposition withdrawn)
(2) AbbVie Inc.
(3) AbbVie Overseas S.à r.l. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 114(2)European Patent Convention Art 83
- Keywords
- Grounds for opposition - insufficiency of disclosure (yes)
Sufficiency of disclosure - undue burden (yes)
Late submitted material - correct exercise of discretion (no) - Catchword
- -
Order
For these reasons it is decided that:
The appeal is dismissed.